利多卡因贴剂市场（2026—2031）
利多卡因贴剂市场规模预计由2026年的6.4902亿美元增至2031年的9.3175亿美元，预测期复合年增长率为7.50%。北美是当前最大市场，亚太地区增长最快。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
利多卡因贴剂市场规模预计由2026年的6.4902亿美元增至2031年的9.3175亿美元，预测期复合年增长率为7.50%。北美是当前最大市场，亚太地区增长最快。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 7.5% | 机构预测 |
| 市场规模 | 2026 | USD 649.02 million | 机构预测 |
| 市场规模 | 2031 | USD 931.75 million | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| adhesive_material | aqueous formulations | 2025 | 62.650% |
| application | post-herpetic neuralgia | 2025 | 59.880% |
| distribution_channel | retail pharmacies | 2025 | 45.670% |
| geography | North America | 2025 | 39.340% |
| product_type | prescription patches | 2025 | 76.560% |
| strength | 5% lidocaine patches | 2025 | 58.450% |
关键结论
- adhesive_material 维度中，aqueous formulations 在 2025 年的公开份额为 62.65%。
- application 维度中，post-herpetic neuralgia 在 2025 年的公开份额为 59.88%。
- distribution_channel 维度中，retail pharmacies 在 2025 年的公开份额为 45.67%。
- geography 维度中，North America 在 2025 年的公开份额为 39.34%。
- product_type 维度中，prescription patches 在 2025 年的公开份额为 76.56%。
- strength 维度中，5% lidocaine patches 在 2025 年的公开份额为 58.45%。
主要参与者
- Hisamitsu Pharmaceutical Co., Inc.
- Scilex Pharmaceuticals Inc.
- Endo Pharmaceuticals Inc.
- Teikoku Seiyaku Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Aging population and neuropathic pain | +2.000% | Global, with concentration in North America, Europe, Japan, and China | Long term (≥ 4 years) |
| Non-opioid localized pain management | +1.800% | North America and Europe, with spillover to Asia-Pacific and South America | Medium term (2-4 years) |
| Over-the-counter self-care access | +1.200% | North America, emerging Asia-Pacific markets, and selected European countries | Short term (≤ 2 years) |
| Improved adhesion and drug delivery | +0.900% | Global, with early gains in North America and Japan | Medium term (2-4 years) |
| Generic and authorized-generic availability | +1.800% | North America and Europe, with spillover to Asia-Pacific and South America | Medium term (2-4 years) |
| Growing online pharmacy and telehealth access | +1.200% | North America, emerging Asia-Pacific markets, and selected European countries | Short term (≤ 2 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Generic price erosion and formulary substitution | -0.900% | North America, with a secondary effect in Europe | Short term (≤ 2 years) |
| Adhesion failure, skin irritation, and delivery variability | -0.600% | Global | Medium term (2-4 years) |
| Narrow approved indication for prescription products | -0.400% | Global | Medium term (2-4 years) |
| Competition from non-patch topical and systemic therapies | -0.500% | Global | Medium term (2-4 years) |
报告关注的关键问题
What is the 2026 value of the lidocaine patches market?
The lidocaine patches market was valued at USD 649.02 million in 2026 and is forecast to reach USD 931.75 million by 2031. This forecast reflects a 7.50% CAGR for the 2026 to 2031 period.
What is driving demand for lidocaine patches?
Demand is supported by non-opioid pain care, aging populations, OTC access, and improved patch adhesion technologies. Reimbursement support and access through retail and online channels also shape purchasing and prescribing.
Which lidocaine patch strength is growing fastest?
The 4% patch segment is forecast to grow at an 8.78% CAGR through 2031, supported by OTC availability. Its growth depends on accessible retail placement, clear dosing, and product performance.
Which product category currently leads sales?
Prescription patches led with 76.56% share in 2025, supported by their established use in post-herpetic neuralgia. Specialist prescribing, formulary access, and clinical familiarity reinforce this position.
Which region is growing fastest for lidocaine patches?
Asia-Pacific is forecast to grow at an 8.94% CAGR through 2031, supported by aging populations and wider retail access. Japan, China, and Southeast Asia contribute through consumer demand and distribution expansion.
Why does patch adhesion matter to patients and manufacturers?
Adhesion affects wear time, dose consistency, comfort, repeat use, and the ability of brands to differentiate from conventional hydrogel products. It also influences whether patients can use a patch reliably during exercise, work, daily routines, and periods of humid weather and normal movement.
市场概览
- 增长最快市场：亚太地区
- 最大市场：北美
- 市场集中度：中等
查看来源：Mordor Intelligence